Medical Oncology· Topic 12.3 Gastrointestinal and hepatobiliary cancers· 12.3.1

Esophageal cancer

Esophageal cancer comprises squamous cell carcinoma, driven by tobacco, alcohol, and caustic or motility injury to the upper and mid esophagus, and adenocarcinoma, arising from GERD-driven Barrett esophagus distally, both presenting with progressive dysphagia from solids to liquids plus weight loss. Diagnosis is by upper endoscopy with biopsy, staged with CT, PET, and endoscopic ultrasound, and treatment is stage-directed from endoscopic resection through esophagectomy with perioperative chemotherapy or chemoradiation to palliative chemoradiation and stenting.

7 min read6 practice questions8 key factsSubscriber article
  • Topic review
    The full article, organized the way the exam asks it.
  • ABIM-format MCQs
    Vignettes with an explanation for every wrong answer.
  • Key facts
    The numbers and thresholds worth memorizing, up front.
  • AI tutor
    MedBrain answers the question you're stuck on.

What this article covers

  • Overview

    Definition: esophageal cancer is a malignancy of the esophageal wall with two distinct histologies, squamous cell carcinoma and adenocarcinoma, that differ in location and risk factors but are diagnosed and staged the same way.

  • Epidemiology

    Global burden and histology split: esophageal cancer causes a large share of cancer deaths worldwide, with highest incidence in Asia and southern and eastern Africa; squamous cell carcinoma is about…

  • Risk factors

    Adenocarcinoma, GERD and Barrett esophagus: chronic gastroesophageal reflux disease drives columnar metaplasia of the distal esophagus into Barrett esophagus, the established precursor lesion, with…

  • Pathophysiology

    Adenocarcinoma sequence: long-standing acid reflux causes intestinal metaplasia of distal esophageal squamous epithelium into Barrett columnar epithelium, which progresses through low-grade and…

  • Clinical features

    Progressive dysphagia: the most common initial symptom, beginning with solid foods and progressing to liquids as the lumen narrows; this pattern distinguishes mechanical obstruction from a motility…

  • Differential diagnosis

    Peptic stricture: progressive solid-food dysphagia with long-standing reflux, but a smooth, tapered narrowing on endoscopy and biopsy without malignant cells.

  • Diagnosis

    Confirm with upper endoscopy and biopsy, the diagnostic test of choice: direct visualization with tissue biopsy establishes the histologic diagnosis (squamous cell carcinoma versus adenocarcinoma)…

  • Management

    Confirm resectability and fitness first with a multidisciplinary upper gastrointestinal cancer team, using TNM stage plus performance status and comorbidity to select a pathway.

  • Complications

    Malignant dysphagia and aspiration: progressive obstruction causes inability to swallow secretions, recurrent aspiration pneumonia, and malnutrition.

  • Prognosis

    Overall 5-year survival is 15% to 25%, reflecting the predominance of locally advanced or metastatic disease at diagnosis.

  • Prevention

    Barrett esophagus surveillance by dysplasia grade: no dysplasia, repeat endoscopy every 3 to 5 years; low-grade dysplasia (expert-confirmed), optimize PPI therapy and repeat endoscopy in 3 to 6…

Read the whole article

Subscribing to Internal Medicine opens every article, the full question bank and MedBrain, on the web, iPhone and Android.